Title

Cellular Hitchhiking of Nanoparticles

Presenter Information

Kaitlyne Powers

Department

Chemical and Biochemical Engineering

Major

Chemical Engineering

Research Advisor

Barua, Sutapa

Advisor's Department

Chemical and Biochemical Engineering

Funding Source

PI's Start Up and Ozark Biomedical Initiative

Abstract

The overall goal of the research is to explore a combinatorial approach in exploiting the specificity of antibody conjugated drug Nano rods with the direction of polyclonal T cells for breast cancer therapy. Nanoparticles are increasingly appearing as a promising tool for non-invasive and targeted delivery of therapeutic agents to breast tumor tissues. Most applications of nanotechnology in drug delivery have focused on improving blood circulation half-lives, or targeting the cancer tissue. However there are challenges to deliver nanoparticles and their payloads into a tumor parenchyma even after they reach the tumor sites. To address this issue, the research will target the drug nanoparticles for an efficient delivery of therapeutic payloads to the breast cancer site, and expand therapeutic benefits. We hypothesize that the attachment of Trastuzumab-conjugated paclitaxel drug Nano rods to natural T cells will enhance their circulation time and substantially alter their anti-tumoral efficacy.

Biography

Kaitlyne Powers is a senior at Missouri University of Science and Technology pursuing a B.S. in Chemical Engineering. She transferred from the University of Missouri St Louis to Missouri S&T in the fall of 2017 to obtain a chemical engineering degree. She wants to work for the pharmaceutical field once she graduates in May 2020 and the undergraduate research Kaitlyne is in is preparing her for that field. The research is giving Kaitlyne hands on experience that she can utilize before graduating to apply to her field of work.

Research Category

Engineering

Presentation Type

Oral Presentation

Document Type

Presentation

Award

Engineering oral presentation, Third place

Location

Ozark Room

Presentation Date

16 Apr 2019, 1:00 pm - 1:30 pm

This document is currently not available here.

Share

COinS
 
Apr 16th, 1:00 PM Apr 16th, 1:30 PM

Cellular Hitchhiking of Nanoparticles

Ozark Room

The overall goal of the research is to explore a combinatorial approach in exploiting the specificity of antibody conjugated drug Nano rods with the direction of polyclonal T cells for breast cancer therapy. Nanoparticles are increasingly appearing as a promising tool for non-invasive and targeted delivery of therapeutic agents to breast tumor tissues. Most applications of nanotechnology in drug delivery have focused on improving blood circulation half-lives, or targeting the cancer tissue. However there are challenges to deliver nanoparticles and their payloads into a tumor parenchyma even after they reach the tumor sites. To address this issue, the research will target the drug nanoparticles for an efficient delivery of therapeutic payloads to the breast cancer site, and expand therapeutic benefits. We hypothesize that the attachment of Trastuzumab-conjugated paclitaxel drug Nano rods to natural T cells will enhance their circulation time and substantially alter their anti-tumoral efficacy.